DT Capital Partners
VC Fund
Shanghai, China
DT Capital Partners is a private equity investment firm that provides growth capital to early and expansion stage companies. They invest in dynamic businesses that have high growth potential, strong management teams, and demonstrated revenue models in both technology-based and traditional industries. DT Capital Partners currently manages over USD$500 Million in capital across multiple US dollar and RMB funds, and also has a close affiliation with Madrone Capital in the US, the investment entity for members of the Walton family. In addition to funds, the invested company also benefits from their extensive experience in operating capital markets across the country, close relationships with local governments and companies, and synergies with other investment companies. DT Capital Partners was awarded the “Top 10 China's Best Return Venture Capital Institution” in 2016, and the founding partners of Detong Capital, Shao Jun and Tian Lixin. DT Capital Partner was founded in 2006 and is based in Shanghai, China.
- Total investments:
- 149
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $286M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries DT Capital Partners invests in
Stages DT Capital Partners invests in
Countries DT Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Series A
- $1.5M–$31M
- Series B
- $2.9M–$90M
- Series C
- $15M–$102M
Investment Focus
Industry
- Health Care 18 (12%)
- Medical 16 (11%)
- Biotechnology 14 (9%)
- Artificial Intelligence 14 (9%)
- Software 13 (9%)
Stage
- Series A 55 (37%)
- Series B 29 (19%)
- Series C 15 (10%)
- Seed 14 (9%)
- Angel 11 (7%)
Country
- China 113 (76%)
- United States 7 (5%)
- South Korea 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chirs Bian
Analyst
|
Analyst | Total investments: 0 | Find email | |
Daniel Lu
Operation Partner
|
Operation Partner | Total investments: 0 | Find email | |
Jason Xu
Partner
|
Partner | Total investments: 0 | Find email | |
Jenny Yu
Analyst
|
Analyst | Total investments: 0 | Find email | |
Kelvin Zhen
Analyst
|
Analyst | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CiMicro.ai is an AI‑chip startup building compute‑in‑memory (CiM)‑based heterogeneous accelerators for high‑efficiency, low‑cost large‑language‑model inference. | $14.9M / Venture - Series Unknown / Oct 14, 2026 | ||
| Honghu Fusion focuses on researching, engineering, and commercializing controlled nuclear fusion reactors by utilizing high-temperature superconducting stellarator designs. The company integrates artificial intelligence, digital twin modeling, and additive manufacturing to design and optimize complex magnetic coil structures. Through its proprietary engineering frameworks and academic joint ventures, it develops compact experimental devices aimed at achieving sustainable, clean commercial energy. | Angel / Sep 21, 2026 | ||
| Yincheng Intelligent is an enterprise focused on developing new types of productivity. It is committed to revolutionizing traditional labor models through advanced embodied intelligence technology, thereby increasing productivity and freeing up human resources. The company provides services in multiple fields, including logistics, pharmaceuticals,chemicals, industry, and home services, building a new development pattern of smart work and smart living. Its main product is currently sorting robots used in the logistics industry. | $14.9M / Series A / Sep 15, 2026 | ||
Villanelle Life
|
Villanelle Life is a biotechnology company that specializes in creating AI drugs, early screening, and auxiliary diagnosis platforms to solve complex diseases. | Seed / Jul 16, 2026 | |
| Mojie is a technology company that engages in the research and development of optics and AI solutions, known for its extensive development of various core technologies. The company operates research and development offices and high-end manufacturing bases. | $88.5M / Series A / Jul 13, 2026 | ||
| Drug Farm is a China and US-based biotech developing innovative treatments targeting innate immunity for HBV, cancer, and autoimmune diseases. Drug Farm's unique IDInVivo platform combines breakthrough technologies in genetics and AI to discover new treatments. | $55M / Series D / Jul 13, 2026 | ||
|
Linkai Semiconductor
|
Linkai Semiconductor designs non-volatile memory and AI storage chips using proprietary ATopFlash© and HBF+ architectures. The company develops high-bandwidth, low-power storage hardware compatible with HBM ecosystems specifically for large-model AI inference scenarios. | Seed / Jul 03, 2026 | |
|
Matrix Optoelectronics Technology
|
Matrix Optoelectronics is a quantum computing technology developer that specializes in the research and development of large-scale fault-tolerant superconducting quantum computing technology. | $29.4M / Angel / May 18, 2026 | |
| CiMicro.ai is an AI‑chip startup building compute‑in‑memory (CiM)‑based heterogeneous accelerators for high‑efficiency, low‑cost large‑language‑model inference. | $14.7M / Seed / May 07, 2026 | ||
|
Linkerbot
|
Lingxin Qiaoshou focuses on the research and development and production of embodied intelligent platforms with "dexterous hands + cloud-based intelligent brain" as the core. | Series B / Apr 29, 2026 | |
| See all 149 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does DT Capital Partners invest in?
DT Capital Partners invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 149 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does DT Capital Partners invest in?
DT Capital Partners typically joins rounds of $1.5M–$31M at Series A, $2.9M–$90M at Series B and $15M–$102M at Series C. These are whole funding-round sizes, not DT Capital Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds DT Capital Partners took part in.
How do I contact DT Capital Partners?
Public channels for DT Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DT Capital Partners?
The team at DT Capital Partners includes Chirs Bian (Analyst), Daniel Lu (Operation Partner) and Jason Xu (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
